1.      Deepak NA, Estsuko H, Laurentius AL, José DS, Pei-JC, Khean-LG, et al. How common is non-alcoholic fatty liver disease in the Asia–Paci c region and are there local differences?. J Gastroenterol Hepatol 2007;22:788–93.

2.      György B, Elizabeth MB, Stephen HC. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012;56:1384–91.

3.      Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non- alcoholic fatty liver disease. Dig Dis. 2010;28(1):155–161. 


4.      Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42(1):44–52.

5.      ames WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263(4):336–352. 


6.      Nimer A. Nutritional recommendations for patients with non-alcoholic fatty liver diseases. World J Gastroenterol 2011;17: 3375-6. 


7.      Bath G, Baba CS, Pandey A, Kumari N, Choudhuri G. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. World J Hepatol 2012;4:209-17. 


8.      Larson-Meyer DE, Newcomer BR, Heilbronn LK, et al; Pennington CALERIE Team. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring). 2008;16 (6):1355–1362.

9.      Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin TL. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. Diabetes Care. 2007;30(5): 1075–1080.

10.  de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R. Effect of two different hypocaloric diets in transaminases and insulin resis- tance in nonalcoholic fatty liver disease and obese patients. Nutr Hosp. 2010;25(5):730–735.

11.  Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB; NASH CRN Research Group. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol. 2011;106(3):460–468; quiz 469. 


12.  Bae JC, Suh S, Park SE, et al. Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in indi- viduals with NAFLD independent of obesity in Korean adults. PLoS One. 2012;7(10):e46819. 


13.  Shira ZS, Vlad R, Ran O. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011;17:3377-89. 


14.  Chalasani N, Younossi Z, Joel EL, Anna MD, Elizabeth MB, Kenneth C, et al. The diagnosis and management of non- alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23. 


15.  Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. NEJM 2004;351:2683–93.

16.  Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. NEJM 2007;357: 741–52.

17.  Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery

18.  Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database System Rev 2010:CD007340.

19.  Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219–229.